BrainScope

BrainScope is a pioneering neurodiagnostics company that has commercialized the first FDA-cleared AI/ML-enabled medical device in neurology for head injury assessment. Its core technology is a proprietary platform that applies computational neuroscience and machine learning to EEG data to generate rapid, objective biomarkers. The company has demonstrated clinical utility in emergency settings, reducing unnecessary CT scans and patient length of stay, and is now leveraging its 'Large Neural Model Platform' to develop biomarkers for a broader range of CNS disorders.

AI-powered EEG analysis platform that uses machine/deep learning and computational neuroscience to de-noise, digitize, and transform raw brain electrical activity into quantitative, actionable biomarkers for CNS disorders. Includes a proprietary FDA-cleared device and a flexible 'Large Neural Model Platform' for third-party EEG data.

BrainScope is a pioneer in FDA-cleared AI/ML for neurology, competing in the TBI space with traditional imaging (CT/MRI) and other emerging digital assessment tools. Its broader platform faces potential competition from other EEG analytics startups, digital biomarker companies, and large tech firms (e.g., Google, Apple) exploring health sensors, though its clinical validation and IP portfolio provide defensibility.